← Back to Search

Other

Muscle Vibration for Chemotherapy-Induced Neuropathy

N/A

Recruiting

Led By David McCall

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of any type of cancer.

History of any type of cancer-

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial is testing a new medical device on patients who have developed neuropathy from chemotherapy. The device's safety and effectiveness will be measured by physical and occupational therapists, and how well patients can perform everyday activities.

Who is the study for?

This trial is for people aged 6-39 with peripheral neuropathy from chemotherapy, who can walk (with support like a walker if needed) and follow the study's procedures. They must understand the study and give consent. It's not for those with lower limb amputations, severe deformities, unstable blood pressure, other risky conditions, or pregnant women.Check my eligibility

What is being tested?

The study tests a vibrating device on patients at MD Anderson who have gait issues due to nerve damage from cancer treatment. The goal is to see how this non-significant risk device affects their walking ability and daily activities.See study design

What are the potential side effects?

Since it's an open-label pilot study of a non-significant risk medical device designed to help control gait in patients with neuropathy, side effects are expected to be minimal but may include discomfort or skin irritation where the device is used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had cancer before.

Select...

I have had cancer before.

Select...

I am between 6 and 39 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

To establish the effect of a vibrating device applied to selected muscles on the step times of adolescent or young adult (AYA).

Trial Design

1Treatment groups

Experimental Treatment

Group I: Vibrating DeviceExperimental Treatment1 Intervention

you will be asked to walk up and down a hallway 5 times with the vibrating device strapped to different parts of your leg.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor

2,985 Previous Clinical Trials

1,789,102 Total Patients Enrolled

David McCallPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Vibrating Device (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05061238 — N/A

Muscle Clinical Trial 2023: Vibrating Device Highlights & Side Effects. Trial Name: NCT05061238 — N/A

Vibrating Device (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05061238 — N/A

Muscle Research Study Groups: Vibrating Device

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor include seniors in its selection criteria?

"This clinical trial necessitates that patients be between the ages of 6 and 39. For those who are younger than 18 or older than 65, there are 1 and 2 trials respectively available to them."

Answered by AI

Is enrollment still open for this medical trial?

"Affirmative. According to the details hosted on clinicaltrials.gov, this research study is recruiting subjects as of now. It was initially posted online in October 2021 and has been updated most recently in August 2022; it seeks 10 participants from a single site."

Answered by AI

Am I qualified to partake in this clinical investigation?

"This trial is recruiting 10 individuals who are aged between 6 and 39, possess muscularity, do not have a prior medical history of malignancy, suffer from peripheral neuropathy-associated gait dysfunction (as diagnosed by their physician), can walk unassisted or with the aid of a walking support device, demonstrate comprehension of the study's purpose and risks in addition to providing signed consent for data use according to local privacy laws. Furthermore, patients wearing ankle foot orthosis must remove them during testing."

Answered by AI

How many participants are being observed for this clinical investigation?

"Affirmative. Data housed on clinicaltrials.gov highlights that this medical study, which was first listed on October 4th 2021, is actively recruiting participants. 10 patients need to be sourced from one specific medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact Of Muscle Vibration On Gait Control

2021. "Impact Of Muscle Vibration On Gait Control". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05061238.